Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.

about

Effect of matrine against breast cancer by downregulating the vascular endothelial growth factor via the Wnt/β-catenin pathway.ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients.

P2860

Q50045926-25A35F0A-F01A-44F1-A519-9C2DFF23996D Q55070017-CAFD84B0-E267-4F4B-B7F6-7B6BCF60288B

P2860

Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.

Item

http://www.wikidata.org/entity/Q51366910

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@en

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@nl

type

Item

label

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@en

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@nl

prefLabel

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@en

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@nl

P1476

Plasma levels and diagnostic u ...... ics of breast cancer patients.

@en

P2093

Edyta Katarzyna Głażewska

http://www.w3.org/2001/XMLSchema#string

Maciej Szmitkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.

Epidemiology of breast cancer: an environmental disease?

The promise of biomarkers in cancer screening and detection.

Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Enhanced immunoreactivity of TIMP-2 in the stromal compartment of tumor as a marker of favorable prognosis in ovarian cancer patients.

Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1354750X.2016.1252955

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sławomir Ławicki

Grażyna Ewa Będkowska

Monika Zajkowska

P577

2016-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27775427

http://www.w3.org/2001/XMLSchema#string

Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.

about

P2860

P2860

Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698